Keep Desiccated Thyroid as a Treatment Option for Hypothyroidism Keep Desiccated Thyroid as a Treatment Option for Hypothyroidism
Time spent in normal thyroid range over 3 years was the same whether patients took levothyroxine or desiccated thyroid; editorial says keeping the latter in the treatment tool kit is important.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

What Happens If Hypothyroidism Is Left Untreated
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 21, 2020 Category: General Medicine Source Type: news

Mayo Clinic Q and A: Hypothyroidism and dietary challenges
DEAR MAYO CLINIC: I was recently diagnosed with hypothyroidism and have been getting conflicting information on what I should eat and drink. I love yogurt and ice cream, for instance, but one source said a calcium-rich diet was fine, whereas another said I should limit dairy. I've also read that I should avoid soy and [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 14, 2020 Category: Databases & Libraries Source Type: news

Effect of Increased Levothyroxine Dose on Depressive Mood Effect of Increased Levothyroxine Dose on Depressive Mood
Increased doses of levothyroxine may help improve depressive symptoms among older hypothyroid patients receiving hormone replacement therapy.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

What Happens If Hypothyroidism Is Left Untreated?
Title: What Happens If Hypothyroidism Is Left Untreated?Category: Diseases and ConditionsCreated: 8/25/2020 12:00:00 AMLast Editorial Review: 8/25/2020 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - August 25, 2020 Category: Endocrinology Source Type: news

What Causes Hypothyroidism?
Title: What Causes Hypothyroidism?Category: Diseases and ConditionsCreated: 8/25/2020 12:00:00 AMLast Editorial Review: 8/25/2020 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - August 25, 2020 Category: Endocrinology Source Type: news

Have I Been Doing This Exam Wrong All This Time? Have I Been Doing This Exam Wrong All This Time?
The Curbsiders share their favorite tips from a jam-packed podcast on hypothyroidism.The Curbsiders (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - August 24, 2020 Category: Universities & Medical Training Tags: Diabetes & Endocrinology Commentary Source Type: news

FDA approves Roche ’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Basel, 31 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq ® (atezolizumab) plus Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients.  The safety profile observed in the Tecentriq combination was consistent with the known safety profiles of the individual medicines. The supplemental Biologics License Application (sBLA) for Tecentriq was granted under priority review.   The review was also conducted under Project Orbis, an initiative of the FDA On...
Source: Roche Media News - July 31, 2020 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Basel, 31 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq ® (atezolizumab) plus Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients.  The safety profile observed in the Tecentriq combination was consistent with the known safety profiles of the individual medicines. The supplemental Biologics License Application (sBLA) for Tecentriq was granted under priority review.   The review was also conducted under Project Orbis, an initiative of the FDA On...
Source: Roche Investor Update - July 31, 2020 Category: Pharmaceuticals Source Type: news

Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI
Screening for and subsequent treatment of subclinical hypothyroidism in patients with acute MI to preserve left ventricular function is not justified, the ThyrAMI-2 trialists conclude.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 24, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Bestselling Author Releases Free Deep Dive Educational Webinar and...
Nationally-known patient advocate and bestselling author Mary Shomon has launched a free educational program on levothyroxine, the most commonly prescribed medication to treat hypothyroidism, and one...(PRWeb July 21, 2020)Read the full story at https://www.prweb.com/releases/bestselling_author_releases_free_deep_dive_educational_webinar_and_book_on_levothyroxine_the_most_prescribed_medication_for_hypothyroidism/prweb17267808.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 21, 2020 Category: Pharmaceuticals Source Type: news

Contribute to survey on treatment of hypothyroidism in Europe
You are invited to contribute to a series of national surveys of physicians on the management of hypothyroidism in Europe (THESIS; Treatment of Hypothyroidism in Europe by Specialists: an International Survey).The survey aims to gather information from physicians on a number of clinical practice topics relating to hypothyroidism. Whereas such data have been published from the US, there are few reflecting European practices. Twenty three European countries are already taking part.To help with the UK survey, which involves completing an online questionnaire, email Dr Carla Moran atcm682@me...
Source: Society for Endocrinology - July 16, 2020 Category: Endocrinology Source Type: news

Newborn Iodine Status Not Tied to Congenital Hypothyroidism
THURSDAY, July 9, 2020 -- Blood iodine concentrations in newborns do not vary for infants with or without congenital hypothyroidism (CH), although they are higher in cases versus controls in the neonatal intensive care unit (NICU), according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 9, 2020 Category: Pharmaceuticals Source Type: news

Subclinical Hypothyroidism Appears Common in Women With Miscarriage Subclinical Hypothyroidism Appears Common in Women With Miscarriage
Among women with a history of miscarriage or subfertility, the prevalence of subclinical hypothyroidism is about 20% when using a TSH cutoff of 2.5 mIU/L.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 2, 2020 Category: Endocrinology Tags: Ob/Gyn & Women ' s Health News Source Type: news

Increased Hypothyroidism Risk Seen in Young Men With HS Increased Hypothyroidism Risk Seen in Young Men With HS
Hidradenitis suppurativa (HS) increases the risk for hypothyroidism in young men, but not in young women or any older adults, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 24, 2020 Category: Consumer Health News Tags: Dermatology News Source Type: news

Mild Thyroid Dysfunction Common in Women With Subfertility
WEDNESDAY, June 17, 2020 -- Among women with a history of miscarriage or subfertility trying for a pregnancy, mild subclinical hypothyroidism (SCH) is common, according to a study published online June 17 in the Journal of Clinical Endocrinology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 17, 2020 Category: Pharmaceuticals Source Type: news

L-T4 Before Breakfast vs at Bedtime in Hypothyroidism L-T4 Before Breakfast vs at Bedtime in Hypothyroidism
When is the best time of day to administer L-thyroxine in patients with hypothyroidism? A new meta-analysis compares the effects of different timings.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 16, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

The Role of Serum Procalcitonin in Predicting Bacterial Sepsis in Patients with Hypothyroidism
Conclusion(s): Despite the thyroidal origin of PCT, hypothyroidism did not affect the diagnostic performance of serum PCT levels in predicting bacterial sepsis or septic shock. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 4, 2020 Category: Consumer Health News Source Type: news

Thyroid Dysfunction in Pregnancy Overdiagnosed, Overtreated
MONDAY, June 1, 2020 -- Current practice patterns relating to testing and management of thyroid-stimulating hormone (TSH) during pregnancy are associated with overdiagnosis and overtreatment of hypothyroidism, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2020 Category: Pharmaceuticals Source Type: news

U.S. FDA Approves New Pediatric Formulation of SIRTURO ® (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multidrug-resistant tuberculosis (MDR‑TB). In the U.S., the medicine should be reserved for use when an effective treatment regimen cannot otherwise be provided. This indication received acceler...
Source: Johnson and Johnson - May 27, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

' Superpotent' Lots of NP Thyroid for Hypothyroidism Recalled in US'Superpotent' Lots of NP Thyroid for Hypothyroidism Recalled in US
Thirteen lots of the combination T4/T3 product have been voluntarily recalled as they may contain 115% of the labeled amount of T3. Patients should not stop taking the pills without medical advice.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 27, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news

How Long Does Neonatal Galactorrhea Last?
Discussion Galactorrhea is a milky discharge from the breast in a non-lactating female. Neonatal galactorrhea is sometimes called “Witch’s Milk” based on ideas from the 17th century or earlier that witches would steal the milk for use in their magic. Infant breasts were often compressed to express the fluid and prevent its collection. During the 19th century, reports of breast inflammation and even abscess were reported because of this practice and it was strongly discouraged, and continues to not be recommended today. Enlargement of neonatal breasts and galactorrhea, both for males and females, is fel...
Source: PediatricEducation.org - May 25, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Brian Added 28 Years to His Life … with Telomere Anti-Aging
In a brand-new study, Ivy League researchers report that they’ve isolated a compound in human stem cells called PAPD5 that can treat “telomere diseases” and reverse cellular aging.1 Of course, like many in mainstream medicine, the first thought is how to turn this natural enzyme into a patented drug that targets stem cells to restore telomeres. It’s yet another example of Big Pharma’s attempt to profit from your God-given genes. But you don’t need a “telomere drug” to reverse cellular aging… In a moment, I’ll show you two natural ways you can easily protect your ...
Source: Al Sears, MD Natural Remedies - May 21, 2020 Category: Complementary Medicine Authors: Dr.A.Sears Tags: Anti-Aging Health Source Type: news

Hypothyroidism and Your Hands
Can You Tell If You Have Hypothyroidism by Looking at Your Hands? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 15, 2020 Category: General Medicine Source Type: news

ERLEADA ® (apalutamide) Significantly Improved Overall Survival in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
RARITAN, NJ, May 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the final analysis of the pivotal Phase 3 SPARTAN study demonstrating ERLEADA® (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved overall survival (OS), compared to ADT alone, in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.[i] Results will be presented at the American Society of Clinical Oncology (ASCO) Virtual Scientific Program (Abstract #5516) beginning May 29th. ERLEADA® ...
Source: Johnson and Johnson - May 14, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

L-Thyroxine Does Not Improve Subclinical Hypothyroidism in ≥65s
TUESDAY, May 5, 2020 -- L-thyroxine does not improve hypothyroid symptoms or tiredness among older adults with subclinical hypothyroidism (SCH) and high symptom burden, according to a study published online May 5 in the Annals of Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 5, 2020 Category: Pharmaceuticals Source Type: news

Common Treatment, Synthroid, May Not Help Seniors With Subclinical Thyroid
MONDAY, May 4, 2020 -- The medication Synthroid (levothyroxine) is often used to treat a condition called subclinical hypothyroidism, but a new study suggests the treatment might be a waste of time. For the study, researchers followed 638 people... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2020 Category: General Medicine Source Type: news

Synthroid May Not Help Seniors With Subclinical Thyroid
MONDAY, May 4, 2020 -- The medication Synthroid (levothyroxine) is often used to treat a condition called subclinical hypothyroidism, but a new study suggests the treatment might be a waste of time. For the study, researchers followed 638 people... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2020 Category: General Medicine Source Type: news

Fragile X in the Family
Discussion Fragile X syndrome (FXS) was first clinically described in 1943 by Martin-Bell and in 1969 Lubs found a fragility at the terminal end of the X chromosome. In 1991, three different research groups independently cloned the mutation for the FMR1 gene (Fragile X mental retardation type 1) which has a CGG triplet expansion. The FMR1 gene codes for the FMR protein which is a major regulator of synaptic plasticity and is expressed in the brain and spermatogonia mainly but many other tissues during fetal and early neonatal development. The number of triplets and methylation correlates with clinical expression (increased...
Source: PediatricEducation.org - April 27, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Patients Say Desiccated Thyroid Better Than Standard Therapy Patients Say Desiccated Thyroid Better Than Standard Therapy
Patients with hypothyroidism taking desiccated thyroid extract such as Armour perceive it works better than synthetic levothyroxine alone, despite lack of data and known risks.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 15, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Patients Say Dessicated Thyroid Better Than Standard Therapy Patients Say Dessicated Thyroid Better Than Standard Therapy
Patients with hypothyroidism taking desiccated thyroid extract such as Armour perceive it works better than synthetic levothyroxine alone, despite lack of data and known risks.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 13, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Does Thyroid Hormone Therapy in Older Age Increase Risk of Death? Does Thyroid Hormone Therapy in Older Age Increase Risk of Death?
Whether or not the mortality finding is real, one expert says, in any case, levothyroxine doesn't make older patients with subclinical hypothyroidism feel any better, so is unwarranted.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 6, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Hypothyroid treatment may increase mortality risk
According to a study published in the the Journal of the Endocrine Society, adults over the age of 65 receiving thyroid replacement therapy may have an increased risk of death by up to 60%.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 1, 2020 Category: Endocrinology Source Type: news

Being Chained to Your Desk Might Harm Your Thyroid
TUESDAY, March 31, 2020 -- Could long hours at the office put you at risk for hypothyroidism? New research suggests it's possible: Hypothyroidism (an underactive thyroid) was more than twice as common in adults who worked 53 to 83 hours a week as in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 31, 2020 Category: General Medicine Source Type: news

Opportunity to help inform better hypothyroid treatment
Thissurvey is your opportunity to provide infromation on how you manage hypothyroid patients who continue to experience symptoms.Around 5-10% of hypothyroid individuals (representing between 75,000 and 150,000 adults in the UK) continue to experience profound and sometimes disabling symptoms, such as fatigue, depression and impaired cognition, in spite of being concordant with treatment and adequately replaced from a biochemical point of view.Dr Adrian Heald, Consultant in Endocrinology at Salford Royal Hospital would value your help in gathering data on how you manage this difficult situation, with a vie...
Source: Society for Endocrinology - March 26, 2020 Category: Endocrinology Source Type: news

Levothyroxine taken in the evening may have greater benefits
Hypothyroidism drug, lethothyroxine, may have greater benefits when taken at bedtime rather than breakfast, according to a study published inClinical Endocrinology.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 4, 2020 Category: Endocrinology Source Type: news

What Are the Different Types of Myasthenia Gravis?
Discussion Myasthenia gravis (MG) is a problem of the neuromuscular junction which causes muscle weakness. It can occur in all ages and have a range of symptoms from mild localized disease to mortality-threatening respiratory failure. MG occurs in 1.7-30 cases/million, with a prevalence of 77.7 cases/million. Pediatric patients comprise 10-15% of all patients with MG. In various Asian populations, the juvenile MG can be up to 50% of all of the MG cases. Fluctuations in muscle weakness is a hallmark of the disease. As a reminder, “[i]n normal synaptic transmission in the neuromuscular junction, the axon is depolarize...
Source: PediatricEducation.org - February 17, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

New NICE guidelines for thyroid disease
NICE have recently published new guidelines on thyroid disease assessment and management. Thyroid disease, comprising thyroid dysfunction and enlargement, is common and often identified in primary care. Conditions causing thyroid dysfunction can be broadly divided into those that result in thyroid gland underactivity (overt and subclinical hypothyroidism) or overactivity (thyrotoxicosis). Hypothyroidism is usually managed by general practitioners. Read thesummary article published inThe BMJ for the most recent recommendations from NICE. (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 10, 2020 Category: Endocrinology Source Type: news

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

What Do You Do For Breast Milk Jaundice?
Discussion Almost all infants in the first few days of life have some elevation of their bilirubin because of the various physiologic changes they undergo in the transition to extra-uterine life. This is a common problem managed by many different inpatient and outpatient healthcare providers. This hyperbilirubinemia is usually unconjugated and resolves in the first 1-2 weeks of life. However, when it does not resolve, health care providers have 3 general paths to follow when considering a cause: inadequate breast milk intake, an underlying organic cause or breast milk jaundice. Inadequate breastfeeding is not uncommon and...
Source: PediatricEducation.org - February 3, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

One Brave Mom-Entrepreneur Sets Out To Solve The Thyroid Care Crisis
January is #ThyroidAwarenessMonth and this mom-entrepeneur and cofounder of Paloma Health is helping to raise awareness and innovate care for hypothyroidism. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 1, 2020 Category: Pharmaceuticals Authors: Anuja Khemka, Contributor Source Type: news

Brown Adipose Tissue Response to Cold in Hypothyroidism Brown Adipose Tissue Response to Cold in Hypothyroidism
New research finds that girls with autoimmune hypothyroidism show reduced brown adipose tissue activation in response to cold stimulation.Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 20, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Older woman presenting with recurrent falls: an unusual manifestation of hypothyroidism - Kwon KY, Lee M, Ju H, Im K.
No abstract is available for this article. Language: en... (Source: SafetyLit)
Source: SafetyLit - January 11, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Subclinical hypothyroidism linked to reduced ovarian reserve
According to a study published inThyroid, subclinical hypothyroidism may reduce ovarian reserve in women over 35 years old. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 10, 2020 Category: Endocrinology Source Type: news

Once-Weekly Thyroxine for Thyroxine-Resistant Hypothyroidism Once-Weekly Thyroxine for Thyroxine-Resistant Hypothyroidism
Once-weekly thyroxine treatment may be a safe and effective option for patients with hypothyroidism, particularly those with thyroxine resistance or poor adherence to standard daily therapy.Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 6, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Overt Hypothyroidism May Up All-Cause Mortality in the Elderly
MONDAY, Dec. 23, 2019 -- Hypothyroidism is significantly associated with increased all-cause mortality, but not cardiovascular mortality, among the elderly, according to a review published online Dec. 12 in the Journal of Clinical Endocrinology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 23, 2019 Category: Pharmaceuticals Source Type: news

Jury Still Out on Whether to Treat Subclincal Hypothyroidism in Elderly Jury Still Out on Whether to Treat Subclincal Hypothyroidism in Elderly
A new systematic review suggests elderly patients with overt hypothyroidism should receive levothyroxine treatment, but for those with subclinical hypothyroidism, the advice is less certain.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 13, 2019 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Jury Still Out on Whether to Treat Subclinical Hypothyroidism in Elderly Jury Still Out on Whether to Treat Subclinical Hypothyroidism in Elderly
A new systematic review suggests elderly patients with overt hypothyroidism should receive levothyroxine treatment, but for those with subclinical hypothyroidism, the advice is less certain.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 13, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Hypothyroidism may increase risk of death in older adults
According to a study published in theJournal of Clinical and Endocrinology Metabolism, adults over the age of 60 with hypothyroidism may have an increased risk of death.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 13, 2019 Category: Endocrinology Source Type: news

PhD Studentship in thyroid hormones
Oxford Brookes University are offering a PhD Studentship in the role of thyroid hormones during fetal growth and development.The aim of this PhD studentship is to investigate the mechanisms by which hypothyroidism in utero influences the activity of the fetal HPA axis.  In collaboration with colleagues at the Universities of Oxford and Cambridge, the project will use immunohistochemistry to assess neuronal networks and pituitary cell populations, and tissue culture to examine the secretory capacity of the fetal pituitary in vitro.For further information contact Dr Alison Forhead:aforhead@brookes.ac.ukEligibility: ...
Source: Society for Endocrinology - November 28, 2019 Category: Endocrinology Source Type: news